Citigroup Inc Prime Medicine, Inc. Transaction History
Citigroup Inc
- $163 Billion
- Q4 2024
A detailed history of Citigroup Inc transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Citigroup Inc holds 47,431 shares of PRME stock, worth $94,387. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,431
Previous 48,071
1.33%
Holding current value
$94,387
Previous $186,000
25.81%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding PRME
# of Institutions
135Shares Held
61MCall Options Held
42.6KPut Options Held
173K-
Alphabet Inc. Mountain View, CA15.1MShares$30 Million3.11% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.15MShares$10.2 Million0.13% of portfolio
-
Black Rock Inc. New York, NY5.11MShares$10.2 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.98MShares$7.92 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.66MShares$7.27 Million0.0% of portfolio
About Prime Medicine, Inc.
- Ticker PRME
- Shares Outstandng 95,730,200
- Market Cap $191M